Eisai
4523.T
₹2,287
Share price
0.95%
Change (1 day)
-31.31%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
EPS for Eisai (4523.T)
EPS in 2023 (TTM): ₹179.60
According to Eisai's latest financial reports the company's current EPS (TTM) is ₹186.61. In 2022 the company made an earnings per share (EPS) of ₹136.99 a decrease over its 2021 EPS that were of ₹608.20.
EPS history for Eisai from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | ₹179.60 | 31.1% |
| 2022 | ₹136.99 | -77.48% |
| 2021 | ₹608.20 | -41.88% |
| 2020 | ₹1,046 | -0.94% |
| 2019 | ₹1,056 | 52.59% |
| 2018 | ₹692.26 | 124.17% |
| 2017 | ₹308.81 | -49.42% |
| 2016 | ₹610.60 | 37.08% |
| 2015 | ₹445.44 | -11.75% |
| 2014 | ₹504.73 | -3.23% |
| 2013 | ₹521.58 | -18.56% |
| 2012 | ₹640.47 | -15.51% |
| 2011 | ₹758.08 | -3.75% |
| 2010 | ₹787.65 | -1.36% |
| 2009 | ₹798.50 |